These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7911865)

  • 1. Thrombophilia: the new factor is old factor V.
    Tuddenham EG
    Lancet; 1994 Jun; 343(8912):1515-6. PubMed ID: 7911865
    [No Abstract]   [Full Text] [Related]  

  • 2. [Resistance to activated protein C--a novel cause of thrombophilia].
    Cycowitz Z; Seligsohn U; Zivelin A; Eldor A
    Harefuah; 1995 Jul; 129(1-2):1-5, 80. PubMed ID: 7557699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis.
    Zöller B; Dahlbäck B
    Lancet; 1994 Jun; 343(8912):1536-8. PubMed ID: 7911873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to activated protein C due to factor V R506Q mutation as a cause of venous thrombosis.
    Dahlbäck B
    Rev Invest Clin; 1997 May; 49 Suppl 1():3-5. PubMed ID: 9291738
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical features in 36 patients homozygous for the ARG 506-->GLN factor V mutation.
    Emmerich J; Alhenc-Gelas M; Aillaud MF; Juhan-Vague I; Jude B; Garcin JM; Dreyfus M; de Moerloose P; Le Querrec A; Priollet P; Berruyer M; Vallantin X; Wolf M; Aiach M; Fiessinger JN
    Thromb Haemost; 1997 Apr; 77(4):620-3. PubMed ID: 9134631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Arg306 mutation of the factor V gene in Korean patients with thrombosis.
    Song KS; Park YS; Kim HK; Choi JR; Park Q
    Haemostasis; 1998; 28(5):276. PubMed ID: 10420078
    [No Abstract]   [Full Text] [Related]  

  • 7. Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation.
    Dahlbäck B
    Semin Thromb Hemost; 1999; 25(3):273-89. PubMed ID: 10443959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent factor V Leiden and prothrombin G20210A gene mutations in a patient with a history of recurrent thrombosis.
    Mandavilli B; Shoup RM; DiGiuseppe JA; Rezuke WN; Tsongalis GJ
    Conn Med; 2000 May; 64(5):259-61. PubMed ID: 10860231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perils in the thrombophilia workup: Frequency and circumstances of erroneously ordered factor V activity tests for thrombophilia.
    Houghton DE; Sud S; Moll S; Rollins-Raval MA
    Vasc Med; 2017 Dec; 22(6):527-528. PubMed ID: 28965480
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of the prothrombin G20210A mutation with factor V Leiden in a midwestern American population.
    Bavikatty NR; Killeen AA; Akel N; Normolle D; Schmaier AH
    Am J Clin Pathol; 2000 Aug; 114(2):272-5. PubMed ID: 10941343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief report: variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg-->Gln mutation in the gene for factor V.
    Greengard JS; Eichinger S; Griffin JH; Bauer KA
    N Engl J Med; 1994 Dec; 331(23):1559-62. PubMed ID: 7969326
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombophilia, homocystinuria, and mutation of the factor V gene.
    Quéré I; Lamarti H; Chadefaux-Vekemans B
    N Engl J Med; 1996 Jul; 335(4):289; author reply 290. PubMed ID: 8657259
    [No Abstract]   [Full Text] [Related]  

  • 13. Factor V Leiden: an overview.
    Shaw DM
    Clin Lab Sci; 2006; 19(4):218-21. PubMed ID: 17181126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexplained thrombosis and factor V Leiden mutation.
    Alhenc-Gelos M; Gandrille S; Aubry ML; Emmerich J; Flessinger JN; Aiach M
    Lancet; 1994 Aug; 344(8921):555-6. PubMed ID: 7914654
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombophilia as a multigenic disorder.
    Seligsohn U; Zivelin A
    Thromb Haemost; 1997 Jul; 78(1):297-301. PubMed ID: 9198169
    [No Abstract]   [Full Text] [Related]  

  • 16. [Activated protein C resistance: role in venous and arterial thrombosis].
    Emmerich J; Alhenc-Gelas M; Aiach M; Fiessinger JN
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):741-5. PubMed ID: 8760661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity and specificity of the APC resistance assay in detection of individuals with factor V Leiden.
    Zehnder JL; Benson RC
    Am J Clin Pathol; 1996 Jul; 106(1):107-11. PubMed ID: 8701918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis.
    Dahlbäck B
    Thromb Haemost; 1997 Jul; 78(1):483-8. PubMed ID: 9198201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of Arg306 mutations of factor V gene.
    Liang R; Lee CK; Wat MS; Kwong YL; Lam CK; Liu HW
    Blood; 1998 Oct; 92(7):2599-600. PubMed ID: 9746807
    [No Abstract]   [Full Text] [Related]  

  • 20. [Activated protein C resistance in the Japanese].
    Ozawa T
    Rinsho Ketsueki; 1996 Sep; 37(9):790-3. PubMed ID: 8914464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.